Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

The end of the trading week likely can't come fast enough for Vanda Pharmaceuticals ( VNDA -6.06%). The commercial-stage ...

There's nothing like a potentially massive government contract to win the hearts of both investors and analysts.

FedEx came up short on top and bottom lines, and guidance revisions suggest there is more bad news to come in fiscal 2025.

The stock market is on fire on Thursday and that has extended to cryptocurrencies as well. Over the past 24 hours, the value ...

Tandem Diabetes Care ( TNDM 4.25%) had some encouraging news to report on the regulatory front Thursday, and after it hit the headlines investors piled into the stock. At the end of the day the highly ...

While the broad stock market was soaring on interest rate cuts today, Skechers ( SKX -9.62%), the casual footwear specialist, was moving in the opposite direction, tumbling after it told investors ...

Argan may be that rarest of beasts: a dividend stock that's also a value and growth-at-a-reasonable-price (GARP) stock.

Shares of biopharma outfit Edgewise Therapeutics ( EWTX 47.93%) soared more than 50% today, reaching a three-year high ...

While many of its chip sector peers have soared this year, ASML has struggled with a cyclical slowdown in the market for semiconductor manufacturing equipment and on recent news of export restrictions ...

Thus far, semiconductor behemoth Nvidia ( NVDA 3.97%) has been the undisputed beneficiary of the rise of AI. But according to ...

Nvidia Stock Has 41% Upside, According to 1 Wall Street Analyst Nvidia's CEO Has Sold Shares Virtually Every Trading Session Since Mid-June. Should Investors Follow Suit and Sell? CEO Jensen Huang ...